A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01789242
Recruitment Status : Completed
First Posted : February 12, 2013
Last Update Posted : October 18, 2017
Information provided by (Responsible Party):
Criterium, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2016
  Study Completion Date : July 2017